Advertisement
Advertisement

PHVS

PHVS logo

Pharvaris N.V. Ordinary Shares

34.91
USD
Sponsored
+0.46
+1.34%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

35.06

+0.16
+0.44%

Pharvaris N.V. Ordinary Shares Profile

About

Pharvaris N.V. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications. Pharvaris N.V. is based in ZUG, Switzerland.

Info & Links

CEO

Berndt Modig

Headquarters

EMMY NOETHERWEG 2
LEIDEN, P7 2333, NETHERLANDS

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.pharvaris.com

Auditor

PricewaterhouseCoopers Accountants N.V.

Share holders

--

Employees

129

Pharvaris N.V. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

2.45B

Enterprise Value

2.16B

Enterprise Value/EBITDA(ttm)

-10.86

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

8.15

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-67.56%

Return on Invested Capital(ttm)

-70.89%

Return on Assets(ttm)

-61.13%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-199.03M

Net Income Available to Common(ttm)

-195.85M

Diluted EPS(ttm)

-3.18

Share Statistics

Beta (5Y Monthly)

-2.31

52-Week Change

71.80%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

57.66M

% Held by Insiders

11.84%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

289.04M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

864.80K

Total Debt/Equity(mrq)

0.31%

Current Ratio(mrq)

11.24%

Quick Ratio(mrq)

11.24%

Book Value Per Share(mrq)

4.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.87

Free Cash Flow(ytd)

-57.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement